Kaleido Biosciences Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Kaleido Biosciences

Access the complete profile.

Kaleido Biosciences Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	124 Washington St Ste 101 Foxborough, MA 02035

Note: Revenues for privately held companies are statistical evaluations.


Kaleido Biosciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Kaleido Biosciences's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Kaleido Biosciences is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Kaleido Biosciences Annual Revenue and Growth Rate

Kaleido Biosciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Kaleido Biosciences's revenues are gauged from an analysis of company filings.

Kaleido Biosciences's Income Statement (based on Industry Averages)

Kaleido Biosciences P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Kaleido Biosciences is developing and marketing. Kaleido Biosciences doesn't have any recent trademark applications, indicating Kaleido Biosciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
MICROBIOME ENHANCER Therapeutic pharmaceuticals for medical use for influencing microbiome imbalances, and treatment of dysbiosis and gastro-intestinal diseases in humans; dietetic foods and beverages adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for influencing and treating microbiome imbalances; hygiene products, namely, medicated body wash; drug testing kits comprised of diagnostic reagents and assays for testing body excretions; diagnostic reagents for medical use	10/06/2016
KALEIDO preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis	10/09/2015

See all trademarks and details in the Full Report.

Market Share of Kaleido Biosciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Kaleido Biosciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Kaleido Biosciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RUBIUS THERAPEUTICS	Foxborough, MA	100
KALEIDO BIOSCIENCES	Foxborough, MA	21
APTINYX	Foxborough, MA	8
1GLOBE HEALTH INSTITUTE	Norwood, MA	8
CORBUS PHARMACEUTICALS	Norwood, MA	7
RARE BEAUTY BRANDS	Norwood, MA	6

Future Competition: Kaleido Biosciences's Fastest Growing Competitors

These companies are in the same general field as Kaleido Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)